Related Experiment Video
Updated: Apr 28, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Provider and patient expectations for dietary supplement discussions
Derjung M Tarn1, Jennifer R Guzmán, Jeffrey S Good
1Department of Family Medicine, David Geffen School of Medicine at UCLA, University of California-Los Angeles, Los Angeles, CA, USA, dtarn@mednet.ucla.edu.
Patients and providers agree on discussing dietary supplements, but patients may overlook costs and regulations. Open communication is key for safe and informed supplement use.
Area of Science:
- Integrative Medicine
- Patient Safety
- Healthcare Communication
Background:
- Widespread dietary supplement use in the U.S. often occurs without provider disclosure.
- Healthcare providers and patients may lack guidance on discussing supplement use during visits.
Purpose of the Study:
- To investigate provider and patient expectations for discussing dietary supplements in clinical settings.
Main Methods:
- Conducted semi-structured interviews with 35 healthcare providers (primary care, integrative medicine, CAM) and 107 patients.
- Employed qualitative analysis using grounded theory and iterative review of interview transcripts.
Main Results:
- Providers and patients identified 12 shared topics for discussion, including supplement risks, benefits, and efficacy.
- Providers frequently raised topics like dosage and evidence, while patients often omitted supplement costs and regulations.
- Complementary and Alternative Medicine (CAM) providers discussed brands and mega-dosing, unlike primary care providers.
Conclusions:
- Shared understanding exists on the importance of discussing supplement use for patient safety.
- Patients may not fully consider cost or regulatory information impacting supplement choices.
- Further research is needed to evaluate comprehensive discussion strategies for informed patient decision-making.
Related Concept Videos
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Bioavailability Study Design: Healthy Subjects Versus Patients
Dosage Regimen: Individualization
Chronic Kidney Disease III: Interprofessional Care
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...

